Epstein File EFTA01199422: Holder, Austin and Solicitation (DS9)

Epstein Index›Documents›EFTA01199422

⚡IMPACT LEVEL 3 — NOTEWORTHY

Epstein File EFTA01199422: Holder, Austin and Solicitation (DS9)

General DocumentDate unavailableEFTA011994221 keyword hits

0

views

0

shares

0

reactions

2

persons

7

keywords

13

excerpts

A technical document discussing healthcare market analysis, focusing on hepatitis C virus (HCV) patient treatment numbers and potential pharmaceutical asset values. The document references US market estimates for antiviral sales and naive patient populations, with financial projections around $1-2B for potential treatments.

👤 Named in This Document

Eric Holder Lloyd Austin

🔑 Evidence Keywords

naive solicitation driver Dubai Tokyo asset professional

📋 Key Excerpts13

PersonKeyword

Excerpt 1

This is a potential source of 2) The number of **naive** US HCV patients treated is stable at -200k/yr, LT risk.

Excerpt 2

We assume: idelalisib can be a $1-2B US asset. 1) ~20B in 2020E antiviral sales, of which -$6B is from HCV, $81 2) The number of **naive** US HCV patients

Excerpt 3

However, we Case 1) ~9B in 2020E antiviral sales, of which ~$500M is from HCV, note expectations are modest. $34 2) The number of **naive** US HCV patients